My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
ARCHIVED REPORTS_2011 REVISED FEASABILITY STUDY
Environmental Health - Public
>
EHD Program Facility Records by Street Name
>
I
>
INDUSTRIAL
>
230
>
2900 - Site Mitigation Program
>
PR0009051
>
ARCHIVED REPORTS_2011 REVISED FEASABILITY STUDY
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
2/5/2020 2:26:35 PM
Creation date
2/5/2020 10:37:50 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2900 - Site Mitigation Program
File Section
ARCHIVED REPORTS
FileName_PostFix
2011 REVISED FEASABILITY STUDY
RECORD_ID
PR0009051
PE
2960
FACILITY_ID
FA0000649
FACILITY_NAME
FORMER NESTLE USA INC FACILITY
STREET_NUMBER
230
STREET_NAME
INDUSTRIAL
STREET_TYPE
DR
City
RIPON
Zip
95366
APN
25938001
CURRENT_STATUS
01
SITE_LOCATION
230 INDUSTRIAL DR
P_LOCATION
05
P_DISTRICT
005
QC Status
Approved
Scanner
SJGOV\sballwahn
Tags
EHD - Public
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
276
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
amec- <br /> 4.0 <br /> CONCLUSIONS <br /> The effectiveness, implementability and cost of a bioaugmentation bio-curtain for treating <br /> dissolved phase contamination near the City of Ripon WWTP Lagoons was evaluated in <br /> Section 3.0. The effectiveness analysis concluded that: <br /> • The effectiveness of groundwater recirculation towards minimizing the risk to <br /> downgradient receptors is low because COC-affected groundwater exists beyond the <br /> alignment of the proposed recirculation system. Intrinsic remediation would be required <br /> to manage the risk of COC impacts to receptors downgradient of the barrier. <br /> Implementation challenges were identified in Section 3.0 of this document are: <br /> • Injection of treated groundwater may be difficult due to well efficiency losses. <br /> • Groundwater treated for CDCs prior to re-injection may still contain TDS and arsenic <br /> above levels established in Waste Discharge Requirements, therefore, it may not be <br /> possible to achieve regulatory approval of such as system. <br /> The total cost for the groundwater recirculation system is estimated to be approximately $59 <br /> million. This approach may not provide an additional reduction in risk towards downgradient <br /> receptors over that which could be obtained with intrinsic remediation. Further, this approach <br /> may not be implementable due to physical limitations and water quality discharge limits <br /> associated with the re-injection of treated groundwater. For these reasons, groundwater <br /> recirculation is not retained for consideration as part of the overall groundwater remedial <br /> action. <br /> 5.0 REFERENCES <br /> EPA, 2007. Options for Discharging Treated Water from Pump and Treat Systems. United <br /> States Environmental Protection Agency. <br /> AMEC Geomatrix, Inc. <br /> \\oad-fs1\doc_safe\9000s\9837.006\4000 REGULATORYTS Assessment_Apx B_012711\Attachment B.3\Attach B-3.docx 133-5 <br />
The URL can be used to link to this page
Your browser does not support the video tag.